Determination of sIgE to rPhl p 1 is sufficient to diagnose grass pollen allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 11, 2013, Pages 1403-1409

  Bokanovic, D ^a   Aberer, W ^a   Hemmer, W ^b   Heinemann, A ^a   Komericki, P ^a   Scheffel, J ^c   Sturm, G J ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b FAZ Floridsdorf Allergy Center   (Austria)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

basophil activation test; component resolved diagnosis; conjunctival provocation test; grass pollen allergy; immuno solid phase allergen chip (ISAC)

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; RPHL P 1 ALLERGEN; UNCLASSIFIED DRUG;

ARTICLE; BASOPHIL ACTIVATION TEST; CLINICAL ARTICLE; CONJUNCTIVAL PROVOCATION TEST; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GRASS POLLEN; HUMAN; PHLEUM PRATENSE; POLLEN ALLERGY; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; SENSITIVITY AND SPECIFICITY; SKIN SENSITIZATION; SKIN TEST;

BASOPHIL ACTIVATION TEST; COMPONENT-RESOLVED DIAGNOSIS; CONJUNCTIVAL PROVOCATION TEST; GRASS POLLEN ALLERGY; IMMUNO SOLID-PHASE ALLERGEN CHIP (ISAC);

ANTIGENS, PLANT; BASOPHILS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; PHLEUM; PLANT EXTRACTS; POLLEN; PROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS;

EID: 84887463019     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12263     Document Type: Article

References (31)

1. Gadermaier E, Staikuniene J, Scheiblhofer S, Thalhamer J, Kundi M, Westritschnig K, et al. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation. Allergy 2011; 66: 1174-1182.
2. Cabrera-Freitag P, Goikoetxea MJ, Beorlegui C, Gamboa P, Gastaminza G, Fernandez-Benitez M, et al. Can component-based microarray replace fluorescent enzimoimmunoassay in the diagnosis of grass and cypress pollen allergy? Clin Exp Allergy 2011; 41: 1440-1446.
3. Sainte-Laudy J, Sabbah A, Drouet M, Lauret MG, Loiry M,. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy 2000; 30: 1166-1171.
4. Sturm GJ, Bohm E, Trummer M, Weiglhofer I, Heinemann A, Aberer W,. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study. Allergy 2004; 59: 1110-1117.
5. Erdmann SM, Sachs B, Kwiecien R, Moll-Slodowy S, Sauer I, Merk HF,. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy. Allergy 2004; 59: 1102-1109.
6. Ebo DG, Hagendorens MM, Bridts CH, De Clerck LS, Stevens WJ,. Hymenoptera venom allergy: taking the sting out of difficult cases. J Investig Allergol Clin Immunol 2007; 17: 357-360.
7. Korosec P, Erzen R, Silar M, Bajrovic N, Kopac P, Kosnik M,. Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results. Clin Exp Allergy 2009; 39: 1730-1737.
8. Bodtger U, Poulsen LK, Malling HJ,. Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 2003; 33: 496-500.
9. Hamilton RG, Saito H,. IgE antibody concentration, specific activity, clonality, and affinity measures from future diagnostic confirmatory tests. J Allergy Clin Immunol 2008; 122: 305-306.
10. Johansson SG, Nopp A, van Hage M, Olofsson N, Lundahl J, Wehlin L, et al. Passive IgE-sensitization by blood transfusion. Allergy 2005; 60: 1192-1199.
11. Nopp A, Johansson SG, Ankerst J, Bylin G, Cardell LO, Gronneberg R, et al. Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006; 61: 298-302.
12. Gronemeyer U,. The conjunctival provocation test. In:, Schultze-Werninghaus G, Fuchs T, Bachert C, Wahn U, editors. Manuale Allergologicum. Germany: Dustri-Verlag Dr. Karl Feistle, 2004: 579-582.
13. Canis M, Groger M, Becker S, Klemens C, Kramer MF,. Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens. Am J Rhinol Allergy 2011; 25: 36-39.
14. Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB,. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol 1988; 82 (5 Pt 1): 869-877.
15. Sturm GJ, Hemmer W, Hawranek T, Lang R, Ollert M, Spillner E, et al. Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergy. J Allergy Clin Immunol 2011; 128: 247-248; author reply 248.
16. Korosec P, Valenta R, Mittermann I, Celesnik N, Silar M, Zidarn M, et al. High sensitivity of CAP-FEIA rVes v 5 and rVes v 1 for diagnosis of Vespula venom allergy. J Allergy Clin Immunol 2012; 129: 1406-1408.
17. Schmid-Grendelmeier P,. Recombinant allergens. For routine use or still only science? Hautarzt 2010; 61: 946-953.
18. Gadisseur R, Chapelle JP, Cavalier E,. A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP(c) 250 with the ImmunoCAP(c) ISAC. Clin Chem Lab Med 2011; 49: 277-280.
19. Altmann F,. The role of protein glycosylation in allergy. Int Arch Allergy Immunol 2007; 142: 99-115.
20. Andersson K, Lidholm J,. Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol 2003; 130: 87-107.
21. Sturm GJ, Jin C, Kranzelbinder B, Hemmer W, Sturm EM, Griesbacher A, et al. Inconsistent results of diagnostic tools hamper the differentiation between bee and vespid venom allergy. PLoS ONE 2011; 6: e20842.
22. Mari A,. IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int Arch Allergy Immunol 2002; 129: 286-295.
23. Moneret-Vautrin DA, Sainte-Laudy J, Kanny G, Fremont S,. Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy. Ann Allergy Asthma Immunol 1999; 82: 33-40.
24. Paris-Kohler A, Demoly P, Persi L, Lebel B, Bousquet J, Arnoux B,. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J Allergy Clin Immunol 2000; 105 (2 Pt 1): 339-345.
25. Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB,. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988; 82 (3 Pt 1): 439-446.
26. Radcliffe MJ, Lewith GT, Prescott P, Church MK, Holgate ST,. Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy 2006; 36: 1488-1493.
27. Van Overtvelt L, Baron-Bodo V, Horiot S, Moussu H, Ricarte C, Horak F, et al. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy. Allergy 2011; 66: 1530-1537.
28. Bilo BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN,. Diagnosis of Hymenoptera venom allergy. Allergy 2005; 60: 1339-1349.
29. Shamji MH, Ljorring C, Francis JN, Calderon MA, Larche M, Kimber I, et al. Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy 2012; 67: 217-226.
30. Rossi RE, Monasterolo G, Monasterolo S,. Measurement of IgE antibodies against purified grass-pollen allergens (Phl p 1, 2, 3, 4, 5, 6, 7, 11, and 12) in sera of patients allergic to grass pollen. Allergy 2001; 56: 1180-1185.
31. Mari A,. Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data. Clin Exp Allergy 2003; 33: 43-51.